Catecholamines in the brain as mediators of amphetamine psychosis.
about
GABAergic interneuron origin of schizophrenia pathophysiology.The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaThe behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drugAnimal models for screening new agents: a behavioural viewIs lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapyBehavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area.The role of dopamine in reward and pleasure behaviour--review of data from preclinical research.Comorbidity of substance abuse with other psychiatric disorders.Amphetamine psychosis or paranoid schizophrenia?Psychiatric disorders: diagnosis to therapyHistamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.Bromperidol, a new butyrophenone neuroleptic: a review.Evaluating glutamatergic transmission in schizophrenia.Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia.Dopamine and incentive learning: a framework for considering antipsychotic medication effects.Midbrain dopamine system electrophysiological functioning: a review and new hypothesis.L-dopa and arousal.Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs.Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain.Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.Differential response to amphetamine in schizophrenia.How amphetamine acts in minimal brain dysfunction.History, epidemiology, and medical complications of nasal inhaler abuse.Amphetamine induces beta-adrenergic receptor supersensitivity.Acupuncture and cholinergic suppression of withdrawal symptoms: an hypothesis.The definition of death: ethical philosophical, and policy confusion.Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.Reversal of ethanol intoxication in humans: an assessment of the efficacy of L-dopa, aminophylline, and ephedrine.Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat.Effects of methamphetamine on single unit activity in rat medial prefrontal cortex in vivo.Pseudocatatonia associated with abuse of amphetamine and cannabis.Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.Regional distribution of monoamines and their metabolites in the human brain.Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
P2860
Q24597790-7D19A4A6-C162-41EB-88A6-36AFA3F8831AQ28210979-B34F8B88-C79F-4E4A-87E4-D8DFB8795C16Q28339992-23E36DD8-AD82-4CAB-B668-BBC17D9FD79EQ28760296-38673982-E16B-49EF-B8B2-37B1BCDE7F8FQ30454141-20AC0F71-D12F-474C-954B-BB1C8C7F4273Q30457808-58BF4A93-0888-467B-B2D8-E092972659EBQ30492329-B8082FE2-BC0F-4942-9357-24C34C015F77Q32027963-7EAD8EC2-7AD9-41C2-ADEB-2C5C4BF32230Q33214750-4AC94DEE-2694-4B65-BB2E-99E581F64E89Q33285122-787DEE19-5D9C-4FE8-8EED-1F496CB56F9AQ33823330-92EBCFAF-74E6-482C-8A44-8F5078C25AF9Q33922884-7F9F29CB-D604-4126-B8C5-2DDDD6AC51F2Q34046119-AC6DD524-EE19-4CE0-B47C-E15B5DACE4AFQ34509725-01AB8740-C965-4BB3-A111-5173A673B1A3Q34696629-B8FF10AC-5A5C-4EA4-85D1-A02B0E267F05Q34707311-F64F35FF-8A4D-4039-A118-36BEAF3AFA87Q35610997-74C2C084-1BF5-4DA0-9C96-A7A5C8EE2EB9Q35785068-AB352BCC-6C43-4773-BE53-5299E9E46113Q36633629-EF500124-4FB9-498F-A0D0-77CD6D3BC2E6Q36696087-324B6792-D5B2-46ED-AF96-EC5E6DEE4B85Q37063565-0639BDDC-6DFE-4AD7-A81B-293E90F2B38EQ37098326-52EC02DD-0C5C-4256-BB0F-8D59CAF560D7Q37437347-EE680A12-FD4E-42CF-BEDD-F70D63BF7641Q39128582-6591FD72-7141-46E1-BD58-286918AA4E40Q39192409-71503A0A-E58D-4C31-9142-5643D2088563Q39228585-995F5C07-D6FB-4207-89E1-D48C24164187Q39549392-B9C5F5F1-8CB6-4241-B8C8-96BCC7DAC8A2Q39923924-6ECEAF69-47B4-473F-9798-4B2310330428Q40089110-D32864F6-DBC7-499B-932F-D3631D03F68CQ40125467-F2C1BE8B-EBBC-4F44-9611-BB3EB1817A88Q40540237-16EEF7CB-9FA2-411E-BE72-0D8B5DBF3B0EQ40585388-F022A083-84DC-45B3-BDD4-565889B9F9FBQ40646471-3733A530-FDAD-4592-96CD-AD98DF0C9126Q41359621-27E7652E-0F98-4055-AC25-1951AB71F562Q41604859-3D39AE2F-330B-4C65-A0D9-99BC737EA181Q42131731-427D2B50-4A32-4165-BB49-7252DB6A8F73Q43964947-FD4F0440-23FF-4FD2-AE90-BB9EDF072006Q44452755-D2AAED18-3331-463D-A16D-A360DDC4AD30Q44581563-4AAB07D7-6FF2-4BDC-BB71-ED3A4C3F969BQ46845870-E2115FE9-D373-4353-8E4E-14E076EEF592
P2860
Catecholamines in the brain as mediators of amphetamine psychosis.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Catecholamines in the brain as mediators of amphetamine psychosis.
@en
Catecholamines in the brain as mediators of amphetamine psychosis.
@nl
type
label
Catecholamines in the brain as mediators of amphetamine psychosis.
@en
Catecholamines in the brain as mediators of amphetamine psychosis.
@nl
prefLabel
Catecholamines in the brain as mediators of amphetamine psychosis.
@en
Catecholamines in the brain as mediators of amphetamine psychosis.
@nl
P1433
P1476
Catecholamines in the brain as mediators of amphetamine psychosis.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1972.01750260021004
P407
P577
1972-08-01T00:00:00Z